APRILLE SINGSON: Open Payments
NPI 1013780766 · CHESAPEAKE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,247 in 92 payments from 17 companies in 2025. Trend: 2023 $42 · 2024 $1,492 · 2025 $2,247
Food & beverage: $2,247
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $569 |
| AstraZeneca Pharmaceuticals LP | 14 | $469 |
| Lilly USA, LLC | 7 | $193 |
| Abbott Laboratories | 8 | $184 |
| Novo Nordisk Inc | 8 | $140 |
| Corcept Therapeutics | 5 | $124 |
| PFIZER INC. | 6 | $119 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $115 |
| Dexcom, Inc. | 5 | $90 |
| Amgen Inc. | 4 | $65 |
Products named: UBRELVY, AIRSUPRA, FREESTYLE LIBRE 3, MOUNJARO, Korlym, BREZTRI, Dexcom G6 Transmitter, JARDIANCE.
Industry payments across VA — which companies pay providers there.
